Latest News about PTCT
Recent news which mentions PTCT
Earnings Scheduled For August 3, 2023
August 03, 2023
From Benzinga
Morgan Stanley Maintains Equal-Weight Rating for PTC Therapeutics: Here's What You Need To Know
July 11, 2023
Tickers
PTCT
From Benzinga
PTC Therapeutics' Seizure Study Fails To Meet Primary Goal, Analyst Says Minimal Impact On Investment Thesis
June 30, 2023
Tickers
PTCT
From Benzinga
PTC Therapeutics Says Interim Data For Huntington's Disease Candidate Shows Promise In Mid-Stage Study
June 21, 2023
Tickers
PTCT
From Benzinga
From InvestorPlace
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
From Benzinga
From Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023
From InvestorPlace
Why Is Ocugen (OCGN) Stock Down 22% Today?
May 24, 2023
From InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 21% Today?
May 24, 2023
From InvestorPlace
From Benzinga
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 24, 2023
From Benzinga
From InvestorPlace
Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 24, 2023
From Benzinga
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
May 18, 2023
From Benzinga
Earnings Scheduled For April 27, 2023
April 27, 2023
From Benzinga
From Benzinga
Looking Into PTC Therapeutics's Return On Capital Employed
February 22, 2023
Tickers
PTCT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
7 Nasdaq Stocks to Sell Before They Plunge in 2023
December 05, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.